Successfully Fast-Track Your LNPs from Concept to Market at the Largest Meeting Dedicated Purely to LNPs Worldwide
With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this delivery vehicle is truly exciting!
The 4th LNP Formulation & Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver.
With a revamped track design, the 2025 meeting has 3 dedicated streams, Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing to deep dive into an end-to-end strategy for revolutionizing the development of potent, safe and stable LNPs for a variety of payloads.
Uniting 300+ LNP trailblazers from across the globe, this is your one-stop-shop for LNP specific networking, partnership opportunities and collaborative discussions to further fuel advancement of LNPs towards clinical development and beyond.
2024 Expert Speakers Include:
What’s on in 2025?
In addition to the unrivalled scientific content in the form of presentations, roundtable discussion, panels and workshops, there will be a variety of extra experiences allowing for maximum ROI out of your time at the conference.
3-Track Conference
The flagship summit is returning to Boston with its famed end-to-end conference programme full of unmissable scientific content in the form of presentations, panels and roundtable discussions. This year, 3 parallel tracks of content will be provided for all members of the team, delve Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing to optimize your LNP development.
LNP 101 Day
The Pre-Conference LNP 101 Day is back! Taking place before the main conference programme kicks off, providing you and your team with the ultimate toolkit containing all the fundamental principles for successful development of LNPs. This day is showcasing the full potential of LNPs across a range of payloads and disease areas.
2-Track Workshop Day
The Pre-Conference Workshop Day will deep dive into key challenges, including lipid library development, extrahepatic delivery, optimizing CMC of LNPs and overcoming IP bottlenecks, to accelerate novel and innovative LNPs towards the market.
Poster Session
Interested in hearing what your peers are up to, or even sharing research of your own? The poster session will unleash the latest innovations as part of the main conference programme for no extra charge.
Networking Opportunities
Nothing says LNP Formulation & Process Development Summit like dedicated networking opportunities! The 2025 meeting will have drinks receptions, speed networking opportunities, lunch briefings and more with 300+ biopharma experts dedicated to progressing LNPs.
New! Awards Evening & Drinks Reception
The inaugural LNP Awards will be happening at the 2025 summit to celebrate success, progress and achievements within the LNP community. You and the LNP community will have your say as we celebrate the very best the industry has to offer.
60+
Expert Speakers
250+
Industry Leaders
10+
Roundtables & Discussions
10+
Hours of Dedicated Networking
2024 Lead Partner:
"Hearing from state-of-the-art scientists and technologies at the front tier of LNPs production, shelf-lie and targeting approaches."
Dan Peer, Vice President for Research & Development,Tel Aviv University
"Lipid Nanoparticles and mRNA therapeutics have entered an exciting stage of development and public awareness.
Bringing together key experts from various stages of discovery, scale-up and manufacturing is important to help spread knowledge and aid further development and utilization of this versatile drug modality"
Michael Munson, Senior Research Scientist, AstraZeneca